<html><body><div style="color:#000; background-color:#fff; font-family:HelveticaNeue, Helvetica Neue, Helvetica, Arial, Lucida Grande, sans-serif;font-size:12pt"><div><span>Dear Tamrat, I Dr VNR Das working in the field of epidemiology and treatment of VL in India, If there is any short of New drug for VL clinincal tial then happy to particept.</span></div><div></div><div> </div><div><font><font><font style="background-color: rgb(255, 255, 255);"><font color="#0000ff"><i><strong>Dr. V N R Das</strong><br><strong>Scientist-E</strong><br></i></font></font></font></font><font size="2"><i>Rajendra Memorial Research Institute of Medical Sciences<br>Indian Council of Medical Research<br>(Department of Health Research) <var id="yui-ie-cursor"></var><br>Ministry of Health & Family Welfare,(Govt. of India)<br>Agamkuan, Patna-800007<br>Phone-0612-2630 096<br>Mobile-094316 46332<br></i>Fax- 091-0612-2634379</font></div><div style="color: rgb(0, 0, 0);
font-family: arial, helvetica, clean, sans-serif; font-size: 13px; font-style: normal; background-color: transparent;"><a href="http://www.rmrims.org.in/" rel="nofollow" target="_blank"><font size="2"><i>www.rmrims.org.in</i></font></a></div><div style="display: block;" class="yahoo_quoted"> <br> <br> <div style="font-family: HelveticaNeue, Helvetica Neue, Helvetica, Arial, Lucida Grande, sans-serif; font-size: 12pt;"> <div style="font-family: HelveticaNeue, Helvetica Neue, Helvetica, Arial, Lucida Grande, sans-serif; font-size: 12pt;"> <div dir="ltr"> <font size="2" face="Arial"> On Thursday, March 27, 2014 7:54 PM, Tamrat Abebe Zeleke <tabebezeleke@gmail.com> wrote:<br> </font> </div> <div class="y_msg_container"><div id="yiv6633557459"><div dir="ltr"><div style="font-family: georgia, serif;" class="yiv6633557459gmail_default">Dear Prof Fortin,<br><br></div><div style="font-family: georgia, serif;"
class="yiv6633557459gmail_default">Congratulations for this break through work. This will be a very good approach to treat cutaneous leishmaniasis one of the most neglected disease. Do you have any plan to test the drug and the approach against other Leishmania species (L. aethiopica)?<br>
<br></div><div style="font-family: georgia, serif;" class="yiv6633557459gmail_default">I would be very much interested to take part in future clinical trial in endemic countries.<br><br></div><div style="font-family: georgia, serif;" class="yiv6633557459gmail_default">
best wishes <br></div><div style="font-family: georgia, serif;" class="yiv6633557459gmail_default"><br></div><div class="yiv6633557459gmail_extra"><br clear="all"><div><div dir="ltr"><div><font face="tahoma, sans-serif"><span style="color: rgb(111, 168, 220);"><div style="font-family: georgia, serif; display: inline;" class="yiv6633557459gmail_default">
Dr. </div>Tamrat Abebe</span><br></font></div><font color="#6fa8dc"><font face="tahoma, sans-serif">Addis Ababa University College of Health Sciences, School of Medicine ,<br>Department of Microbiology, Immunology & Parasitology </font></font><div>
<font color="#6fa8dc"><font face="tahoma, sans-serif">Tikur Anbessa Hospital</font></font></div><div><font color="#6fa8dc"><font face="tahoma, sans-serif">Second floor room number 76<br>Tel: +251 911 447227(mobile)<br><div style="font-family: georgia, serif; display: inline;" class="yiv6633557459gmail_default">
P.O.Box 9086, Addis Ababa, Ethiopia</div><br>Email:</font><font face="comic sans ms, sans-serif"> </font><a href="mailto:tamrat.abebe@aau.edu.et" rel="nofollow" target="_blank" ymailto="mailto:tamrat.abebe@aau.edu.et"><font face="tahoma, sans-serif">tamrat.abebe@aau.edu.et</font></a></font><div>
<font color="#6fa8dc" face="comic sans ms, sans-serif"><b><br></b></font><div><font color="#666666" face="comic sans ms, sans-serif"><b><br></b></font> <br><br> <br></div></div></div></div></div>
<br><br><div class="yiv6633557459gmail_quote">On Thu, Mar 13, 2014 at 1:31 PM, Anny Fortin <span dir="ltr"><<a href="mailto:anny.fortin@mcgill.ca" rel="nofollow" target="_blank" ymailto="mailto:anny.fortin@mcgill.ca">anny.fortin@mcgill.ca</a>></span> wrote:<br><blockquote style="margin: 0px 0px 0px 0.8ex; padding-left: 1ex; border-left-color: rgb(204, 204, 204); border-left-width: 1px; border-left-style: solid;" class="yiv6633557459gmail_quote">
<div>
<div style="font-family: Tahoma; font-size: 10pt; direction: ltr;">
<div>Dear all, I invite you to look at my most recent paper:</div>
<div> </div>
<h1><font size="4">Drug Delivery by Tattooing to Treat Cutaneous Leishmaniasis</font></h1>
<div><a href="http://www.nature.com/srep/2014/140224/srep04156/full/srep04156.html" rel="nofollow" target="_blank">http://www.nature.com/srep/2014/140224/srep04156/full/srep04156.html</a></div>
<div> </div>
<div> </div>
<div> </div>
<div>Anny Fortin</div>
</div>
<br><br>--<br>
<i> This email was sent by <a href="http://icb.usp.br/" rel="nofollow" target="_blank">icb.usp.br</a> </i>
­­ </div>
<br>_______________________________________________<br>
Leish-l mailing list<br>
<a href="mailto:Leish-l@lineu.icb.usp.br" rel="nofollow" target="_blank" ymailto="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</a><br>
<a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" rel="nofollow" target="_blank">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a><br>
<br>
--<br>
This email was sent by <a href="http://icb.usp.br/" rel="nofollow" target="_blank">icb.usp.br</a><br>
<br></blockquote></div><br></div></div>
<br><br>--<br>
<i> This email was sent by icb.usp.br </i>
­­ </div><br>_______________________________________________<br>Leish-l mailing list<br><a href="mailto:Leish-l@lineu.icb.usp.br" ymailto="mailto:Leish-l@lineu.icb.usp.br">Leish-l@lineu.icb.usp.br</a><br><a href="http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l" target="_blank">http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/leish-l</a><br><br>--<br>This email was sent by icb.usp.br<br><br><br></div> </div> </div> </div> </div></body></html>